THE PRIMARY ANTIOXIDANT POWERHOUSE
1 MILLION TIMES MORE POWERFUL THAN ORDINARY ANTIOXIDANTS!
CRYSTACEUTICALS® SOD GLUTATHIONE PLUS effectively restores and activates the body’s primary antioxidant levels including SOD, Catalase and Glutathione Peroxidase (GPx). Primary antioxidants are 1 MILLION TIMES more powerful than secondary antioxidants in eliminating free radicals, providing first line antioxidant defence against Reactive Oxygen Species (ROS).
GliSODin® Cantaloupe Melon Extract
(ISOCELL NUTRA, FRANCE)
The orally effective form of SOD
UV PROTECTION ALL YEAR ROUND, INSIDE OUT!
Recommended by dermatologists worldwide, GliSODin® is a proprietary cantaloupe melon extract developed by ISOCELL NUTRA, France. GliSODin® provides bioactive SOD which is coated and protected by gliadin, a wheat protein that guards SOD during digestion. Gliadin proteins protect SOD against the acids and digestive enzymes produced in the gastrointestinal tract, ensuring high stability & optimal bio-absorption.
GliSODin® protects the skin against sun-associated photoageing, increases the skin’s resistance to UV damage, as well as brightens skin tone & luminosity. GliSODin® also improves skin microcirculation, optimises skin collagen structure & elasticity, and expedites skin healing.
IMPROVES SKIN MELASMA & HYPERPIGMENTATION UP TO 51.93%
In a randomised, open label, five-arm, controlled study for 12 weeks, GliSODin® intake of 250IU daily as an add-on to topical melasma treatment has been proven effective to significantly reduce Melasma Area and Severity Index (MASI) score in melasma patients (n=90) by up to 51.93% (p<0.05).
INCREASES ANTIOXIDANT ENZYMES SOD, GPx & CATALASE
GliSODin® supplementation significantly increases antioxidant status by activating Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx) and Catalase (CAT); the 3 essential primary internal antioxidants that are commonly depleted due to ageing and chronic diseases.
IMPROVES RESPIRATORY & IMMUNE SYSTEM
In human clinical trial, GliSODin® intake of 250IU per day is proven to accelerate symptomatic relief in 40 children aged 6-17 years old with asthma, tested positive for house dust mite allergy and received House Dust Mite Immunotherapy. GliSODin® significantly improved lung function, respiratory symptoms & breathing capacity in 4 weeks.
GliSODin® demonstrates novel immunological benefits by regulating the activation state of macrophages. GliSODin® decreases the production of pro-inflammatory cytokines TNF-α and increases the production of anti-inflammatory cytokines IL-10. This mechanism extends the nutraceutical potential to downregulate cytokine storm, the pathogenic condition in Covid-19.
OPTIMISING LIVER HEALTH & REDUCING LIVER FAT SYNTHESIS
Clinical findings highlighted that GliSODin® helps to reduce liver inflammation, suppress fat accumulation in the liver & prevent liver fibrosis. GliSODin® was shown to improve plasma lipid parameters including total cholesterol, triglycerides (TG) & non-esterified fatty acid (NEFA), improve fatty liver, improve mitochondrial functions and reduce oxidative stress.
GliSODin® prevents diet-induced Non-Alcoholic Steatohepatitis (NASH) onset by reducing fat synthesis and improving liver functions.
OPITAC® L-Glutathione
(MITSUBISHI CORPORATION LIFE SCIENCES LTD, JAPAN)
Clinically tested form of Glutathione = Real Results
PHARMACEUTICAL GRADE, PROVEN BIOAVAILABILITY!
OPITAC® delivers L-Glutathione in its active reduced form, with proven absorption rate up to 90% (p<0.01) from 60 to 120 mins after supplementation.
BRIGHTENS SKIN, BALANCES SKIN TONE, ENHANCES SKIN CLARITY
OPITAC® demonstrates significant skin brightening properties by inhibiting eumelanin (dark pigment) production, improves melasma spots and promotes even skin tone. When taken with collagen peptides, OPITAC® enhances collagen production, synergising skin clarity and elasticity while protecting the skin against the deleterious effects of ageing.
OPITAC® - The only L-Glutathione in the world being granted U.S. Patent (US 11,207,371 B2) as an active ingredient for improvement or prevention of Non-Alcoholic Fatty Liver Disease (NAFLD)
Oral supplementation of OPITAC® L-Glutathione (300 mg/day) for 4 months in twenty nine (n=29) NAFLD patients has been shown to improve NAFLD outcomes, with ALT levels found to be significantly decreased (p=0.014). In addition, triglycerides (p=0.007), non-esterified fatty acids (p=0.013), and ferritin (p=0.015) levels also decreased with OPITAC® treatment.